SpringWorks Therapeutics ...

NASDAQ: SWTX · Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

SpringWorks Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
63.77M 69.75M 84.46M 79.9M 118.03M 176.05M 98.89M 115M 102.4M 67.49M 476.43M 69.57M 81.93M 103.96M 93.85M 84.57M 95.43M
Short-Term Investments
224.1M 238.23M 292.16M 303.99M 318.55M 303.15M 323.52M 361.71M 425.74M 524.72M 175.51M 264.97M 266.34M 269.54M 334.06M 378.21M 381.99M
Long-Term Investments
94.78M 158.12M 121.5M 138.05M 146.19M 185.34M 3.79M 4.81M 5.71M 8.99M 4.87M 6.36M 35.02M 62.11M 55.91M 48.16M 67.24M
Other Long-Term Assets
28.43M 6.47M 26.9M 23.39M 14.77M 4.25M 4.09M 3.61M 3.5M 3.23M 3M 3.24M 3.22M 3.27M 3.02M 2.78M 3.11M
Receivables
40.35M 46.24M 32.97M 24.5M 15.53M 5.93M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
12.42M 10.21M 9.83M 7.72M 5.22M 3.1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
15.68M 16.03M 15.69M 15.22M 14.47M 12.68M 9.96M 7.19M 9.52M 7.55M 5.34M 7.46M 7.68M 9.41M 5.1M 4.21M 4.1M
Total Current Assets
356.32M 380.46M 435.11M 431.32M 471.8M 500.91M 432.38M 483.9M 537.66M 599.76M 657.29M 342M 355.95M 382.91M 433.01M 466.99M 481.51M
Property-Plant & Equipment
25.83M 26.66M 25.36M 24.57M 24.08M 24.09M 27.39M 25M 22.33M 18.27M 16.39M 14.32M 11.39M 4.2M 3.33M 2.5M 2.72M
Goodwill & Intangibles
n/a 15.56M n/a n/a n/a 11.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
149.04M 206.81M 173.77M 186.01M 185.03M 224.88M 35.27M 33.43M 31.54M 30.48M 24.27M 23.92M 49.63M 69.58M 62.26M 53.44M 73.07M
Total Assets
505.36M 587.28M 608.88M 617.33M 656.83M 725.79M 467.65M 517.33M 569.2M 630.24M 681.55M 365.92M 405.58M 452.49M 495.27M 520.43M 554.59M
Account Payables
14.93M 12.25M 9.65M 7.89M 7.01M 7.4M 5.55M 3.45M 6.99M 8.01M 4.59M 2.19M 1.65M 3.43M 2.5M 3.9M 2.23M
Deferred Revenue
n/a n/a n/a 14.63M 4.65M 4.14M 3.24M 2.36M 1.69M 3.31M n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a 958K n/a 1.06M 1.16M 811K 386K n/a 733K 511K 327K n/a 1.26M 1.25M 1.24M
Other Current Liabilities
15.6M 31.22M 59.73M 29.66M 39.15M 38.46M 22.13M 22.21M 19.17M 20.1M 31.21M 23.05M 16.4M n/a 17.11M 12.79M 12.09M
Total Current Liabilities
82.27M 99.99M 70.61M 54.5M 68.92M 78.17M 50.28M 41.91M 37.75M 51.05M 49.49M 34.91M 23.24M 29.97M 28.1M 23.01M 18.73M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 14.66M n/a n/a n/a 131K 131K 131K
Total Long-Term Liabilities
5.69M 6.18M 5.68M 6.1M 20.48M 21.4M 22.47M 23.98M 24.52M 21M 19.66M 5.27M 5.54M 129K 498K 832K 1.16M
Total Liabilities
87.96M 106.17M 76.3M 60.6M 89.39M 99.57M 72.75M 65.89M 62.27M 72.05M 69.15M 40.19M 28.78M 30.1M 28.6M 23.84M 19.89M
Total Debt
7.39M 7.91M 6.91M 7.06M 6.56M 7.06M 7.33M 7.61M 7.05M 5.25M 5.73M 5.78M 5.87M 1.29M 1.62M 1.95M 2.27M
Common Stock
8K 7K 7K 7K 7K 7K 6K 6K 6K 6K 6K 5K 5K 5K 5K 5K 5K
Retained Earnings
-1.24B -1.15B -1.08B -1.02B -982.42M -895.03M -800.71M -721.27M -643.35M -569.93M -495.75M -423.36M -354.31M -292.51M -236.44M -195.4M -148.39M
Comprehensive Income
442K 304K 1.61M -520K -113K 1.19M -313K -352K -162K -767K -1.51M -1.82M -1.46M -312K 24K 25K 53K
Shareholders Equity
417.39M 481.1M 532.58M 556.73M 567.44M 626.22M 394.9M 451.44M 506.92M 558.19M 612.4M 325.73M 376.8M 422.4M 466.68M 496.58M 534.7M
Total Investments
318.88M 396.36M 413.67M 450.04M 464.74M 488.49M 323.52M 361.71M 425.74M 529.52M 180.39M 271.33M 301.36M 331.65M 389.98M 426.36M 449.23M